DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

NCT06504381 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

High Grade Glioma
MGMT-Unmethylated Glioblastoma
MGMT-Methylated Glioblastoma

Interventions

GENETIC: DB107-RRV
DRUG: DB107-FC
RADIATION: Radiation Therapy (RT)
DRUG: Temozolomide
PROCEDURE: Magnetic Resonance Imaging (MRI)
PROCEDURE: Surgical resection

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]